DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Underperform and maintains $17.5 price target.
DA Davidson Maintains Underperform on Medifast, Maintains $17.5 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.